- Rewriting the book on BRD treatment – Zelnate is a new chapter in BRD management
- It's not an antibiotic; it's not a vaccine; it's Zelnate
Indicated for use as an aid in the treatment of BRD due to mannheimia haemolytica in cattle 4 months of age or older, when administered at the time of, or within 24 hours after, a perceived stressful event. Zelnate is the first licensed immunostimulant that aids in the treatment of BRD associated with Mannheimia Haemolytica. The key difference between Zelnate and other immunostimulants lies in its revolutionary DNA-liposome complex. The Zelnate DNA has a unique code that mimics infection, causing the animal's immune system to recognize Zelnate as foreign. By jumpstarting the innate immune system – which has been shown to provide a rapid, potent and broad protective response to infectious agents – Zelnate helps reduce lung lesions and mortality in cattle.
Directions: Rehydrate and inject 2 ml IM at time of, or within 24 hours after, a perceived stressful event. 21 day slaughter withdrawal.